Alcon AG
ALC86.020USD
-0.180-0.21%
Trading geöffnet （ET）Kurse um 15 Minuten verzögert
42.55BMarktkapitalisierung
41.79KGV TTM
mehr Informationen über Alcon AG Unternehmen
Alcon AG is a Switzerland-based eye care company. The Company research, develop, manufacture, distribute and sell a full suite of eye care products within two key businesses: Surgical and Vision Care. The Company’s Surgical business is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery. The surgical portfolio includes implantables, consumables and surgical equipment required for these procedures and supports the end-to-end needs of the ophthalmic surgeon. The Company’s Vision Care business comprises of daily disposable, reusable and color-enhancing contact lenses and a portfolio of ocular health products, including products for dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The Company operates in 60 countries and serves consumers and patients in over 140 countries.
Unternehmensinformationen
BörsenkürzelALC
Name des UnternehmensAlcon AG
IPO-datumApr 09, 2019
Gegründet am2018
CEOMr. David J. Endicott
Anzahl der mitarbeiter25599
WertpapierartOrdinary Share
GeschäftsjahresendeApr 09
AddresseRue Louis d'Affry 6
StadtFRIBOURG
BörseSIX Swiss Exchange
LandSwitzerland
Postleitzahl1700
Telefon41589113800
Websitehttps://www.alcon.ch/
BörsenkürzelALC
IPO-datumApr 09, 2019
Gegründet am2018
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. David J. Endicott
Mr. David J. Endicott
Chief Executive Officer, Director
Chief Executive Officer, Director
207.11K
-11.08%
Mr. Timothy C. (Tim) Stonesifer
Mr. Timothy C. (Tim) Stonesifer
Chief Financial Officer
Chief Financial Officer
134.23K
+38.34%
Mr. Rajkumar Narayanan
Mr. Rajkumar Narayanan
Senior Vice President, President - International
Senior Vice President, President - International
37.83K
+9.30%
Mr. Ian Bell
Mr. Ian Bell
Chief Operating Officer
Chief Operating Officer
30.23K
-24.88%
Ms. Karen J. May, CPA
Ms. Karen J. May, CPA
Independent Director
Independent Director
28.32K
+11.14%
Mr. Laurent Attias
Mr. Laurent Attias
Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)
Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)
22.62K
+15.19%
Mr. Scott Harlan Maw
Mr. Scott Harlan Maw
Independent Director
Independent Director
17.26K
+14.57%
Ms. Ines Poeschel
Ms. Ines Poeschel
Independent Director
Independent Director
12.08K
+15.09%
Ms. Lynn Dorsey Bleil
Ms. Lynn Dorsey Bleil
Independent Director
Independent Director
10.94K
+13.26%
Mr. Leon Sergio Duplan Fraustro
Mr. Leon Sergio Duplan Fraustro
Senior Vice President, President - Americas
Senior Vice President, President - Americas
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. David J. Endicott
Mr. David J. Endicott
Chief Executive Officer, Director
Chief Executive Officer, Director
207.11K
-11.08%
Mr. Timothy C. (Tim) Stonesifer
Mr. Timothy C. (Tim) Stonesifer
Chief Financial Officer
Chief Financial Officer
134.23K
+38.34%
Mr. Rajkumar Narayanan
Mr. Rajkumar Narayanan
Senior Vice President, President - International
Senior Vice President, President - International
37.83K
+9.30%
Mr. Ian Bell
Mr. Ian Bell
Chief Operating Officer
Chief Operating Officer
30.23K
-24.88%
Ms. Karen J. May, CPA
Ms. Karen J. May, CPA
Independent Director
Independent Director
28.32K
+11.14%
Mr. Laurent Attias
Mr. Laurent Attias
Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)
Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)
22.62K
+15.19%
Umsatzaufteilung
Währung: USDAktualisiert: Sun, Apr 6
Währung: USDAktualisiert: Sun, Apr 6
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Consumables
2.86B
29.09%
Contact lenses
2.61B
26.53%
Implantables
1.77B
18.05%
Ocular health
1.71B
17.33%
Equipment/other
886.00M
9.01%
Nach RegionUSD
Name
Umsatz
Anteil
United States
4.51B
45.86%
Other
4.13B
42.01%
China
560.00M
5.69%
Japan
554.00M
5.63%
Switzerland
79.00M
0.80%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Consumables
2.86B
29.09%
Contact lenses
2.61B
26.53%
Implantables
1.77B
18.05%
Ocular health
1.71B
17.33%
Equipment/other
886.00M
9.01%
Aktionärsstatistik
Aktualisiert: Tue, May 20
Aktualisiert: Tue, May 20
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
BlackRock Advisors (UK) Limited
4.94%
The Vanguard Group, Inc.
3.98%
Fidelity Management & Research Company LLC
3.01%
Norges Bank Investment Management (NBIM)
2.53%
Aristotle Capital Management, LLC
2.45%
Other
83.10%
Aktionäre
Aktionäre
Anteil
BlackRock Advisors (UK) Limited
4.94%
The Vanguard Group, Inc.
3.98%
Fidelity Management & Research Company LLC
3.01%
Norges Bank Investment Management (NBIM)
2.53%
Aristotle Capital Management, LLC
2.45%
Other
83.10%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor/Hedge Fund
28.89%
Investment Advisor
27.17%
Bank and Trust
4.28%
Sovereign Wealth Fund
2.61%
Hedge Fund
2.37%
Research Firm
1.61%
Pension Fund
1.40%
Individual Investor
0.13%
Insurance Company
0.10%
Other
31.43%
Institutionelle Beteiligung
Aktualisiert: Sun, Jan 19
Aktualisiert: Sun, Jan 19
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q1
1620
379.56M
75.96%
+37.51M
2024Q4
1636
370.45M
74.13%
+31.24M
2024Q3
1624
333.39M
66.72%
-2.12M
2024Q2
1594
337.16M
67.47%
-33.61M
2024Q1
1583
337.34M
67.51%
+4.25M
2023Q4
1598
326.79M
65.39%
-10.87M
2023Q3
1582
325.37M
65.11%
-21.48M
2023Q2
1575
329.22M
65.88%
-15.79M
2023Q1
1566
324.92M
65.02%
+2.70M
2022Q4
1564
305.91M
61.22%
-40.51M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
BlackRock Advisors (UK) Limited
24.68M
4.94%
--
--
Dec 31, 2024
The Vanguard Group, Inc.
19.35M
3.87%
+211.11K
+1.10%
Dec 31, 2024
Fidelity Management & Research Company LLC
12.09M
2.42%
+611.30K
+5.32%
Dec 31, 2024
Norges Bank Investment Management (NBIM)
12.62M
2.53%
+276.47K
+2.24%
Dec 31, 2024
Aristotle Capital Management, LLC
12.83M
2.57%
-82.71K
-0.64%
Dec 31, 2024
UBS Fund Management (Switzerland) AG
11.93M
2.39%
+211.04K
+1.80%
Dec 31, 2024
Zürcher Kantonalbank (Asset Management)
8.93M
1.79%
+306.70K
+3.56%
Dec 31, 2024
Harding Loevner LP
8.48M
1.7%
-795.85K
-8.58%
Dec 31, 2024
AKO Capital LLP
5.88M
1.18%
-281.54K
-4.57%
Dec 31, 2024
T. Rowe Price Investment Management, Inc.
15.08M
3.02%
+8.71M
+136.76%
Feb 03, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Fri, Jun 6
Aktualisiert: Fri, Jun 6
Name
Anteil
iShares MSCI Switzerland ETF
2.8%
Franklin FTSE Switzerland ETF
2.79%
Global X Aging Population ETF
2.72%
First Trust Switzerland Alphadex Fund
2.33%
Running Oak Efficient Growth ETF
1.89%
First Trust Indxx Medical Devices ETF
1.84%
Global X S&P Catholic Values Developed ex-US ETF
1.33%
BNY Mellon Women's Opportunities ETF
1.28%
Nuveen Growth Opportunities ETF
0.78%
iShares Health Innovation Active ETF
0.66%
Mehr Anzeigen
iShares MSCI Switzerland ETF
Anteil2.8%
Franklin FTSE Switzerland ETF
Anteil2.79%
Global X Aging Population ETF
Anteil2.72%
First Trust Switzerland Alphadex Fund
Anteil2.33%
Running Oak Efficient Growth ETF
Anteil1.89%
First Trust Indxx Medical Devices ETF
Anteil1.84%
Global X S&P Catholic Values Developed ex-US ETF
Anteil1.33%
BNY Mellon Women's Opportunities ETF
Anteil1.28%
Nuveen Growth Opportunities ETF
Anteil0.78%
iShares Health Innovation Active ETF
Anteil0.66%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
400.00M
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Mar 01, 2022
ALC.NB Final Cash Dividend of gross CHF 0.2 paid on May 05, 2022 going ex on Apr 29, 2022
May 04, 2022
May 05, 2022
May 03, 2022
Feb 24, 2021
ALC.NB Final Cash Dividend of gross CHF 0.1 paid on May 06, 2021 going ex on May 04, 2021
May 05, 2021
May 06, 2021
May 04, 2021
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
